Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human DYNC1H1 Protein, N-His

Catalog #:   YHG75501 Specific References (49) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q14204
Protein length: Ala20-Leu285
Overview

Catalog No.

YHG75501

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ala20-Leu285

Predicted molecular weight

32.19 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q14204

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

DNECL, DNCH1, DHC1, DNCL, Cytoplasmic dynein 1 heavy chain 1, DYNC1H1, DYHC, Cytoplasmic dynein heavy chain 1, KIAA0325, Dynein heavy chain, cytosolic

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human DYNC1H1 protein
References

Analysis of the DYNC1H1 Gene Polymorphic Variants' Association with ASD Occurrence and Clinical Phenotype of Affected Children., PMID:40428333

Genetic aetiologies in relation to response to the ketogenic diet in 226 children with epilepsy., PMID:40290421

Comprehensive Proteomics and Machine Learning Analysis to Distinguish Follicular Adenoma and Follicular Thyroid Carcinoma from Indeterminate Thyroid Nodules., PMID:40205804

[A variant of p.Arg1623Gln of the DYNC1H1 gene in a patient with corpus callosum agenesis, polydactyly, mental development disorder, and neuromuscular system disorders]., PMID:40047846

Effect of Dync1h1 on Phototransduction Protein Transport and the Development and Maintenance of Photoreceptor Cells in Zebrafish., PMID:39946138

Effectiveness and Impact of Transcript Analysis in Clinical Genetics Daily Practice., PMID:39707869

Anatomo-Electro-Clinical Phenotypes in Children With Epilepsy and DYNC1H1 Mutations., PMID:39631264

Loss of Dnah5 Downregulates Dync1h1 Expression, Causing Cortical Development Disorders and Congenital Hydrocephalus., PMID:39594631

CNKSR2 interactome analysis indicates its association with the centrosome/microtubule system., PMID:39359098

Characterization of the Epileptogenic Phenotype and Response to Antiseizure Medications in Lissencephaly Patients., PMID:39214127

Candidate proteins interacting with cytoskeleton in cells from the basal airway epithelium in vitro., PMID:39139811

Exploring unsolved cases of lissencephaly spectrum: integrating exome and genome sequencing for higher diagnostic yield., PMID:39123069

Patient-specific mutation of Dync1h1 in mice causes brain and behavioral deficits., PMID:39025270

Congenital syndromic Chiari-like malformation (CSCM) in Holstein cattle: towards unravelling of possible genetic causes., PMID:38965607

Clinical features and genotype-phenotype correlations in epilepsy patients with de novo DYNC1H1 variants., PMID:38953796

The expanding clinical and genetic spectrum of DYNC1H1-related disorders., PMID:38848546

Multidisciplinary approach on divergent outcomes in spinal muscular atrophies: comparing DYNC1H1 and SMN1 gene mutations., PMID:38806879

PRMT5-mediated arginine methylation of FXR1 is essential for RNA binding in cancer cells., PMID:38709899

An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma., PMID:38627727

Aggrephagy-related gene signature correlates with survival and tumor-associated macrophages in glioma: Insights from single-cell and bulk RNA sequencing., PMID:38454689

Novel lissencephaly-associated NDEL1 variant reveals distinct roles of NDE1 and NDEL1 in nucleokinesis and human cortical malformations., PMID:38194050

De novo variants underlying monogenic syndromes with intellectual disability in a neurodevelopmental cohort from India., PMID:38114583

miR-134-3p driven by anisomycin impairs ovarian cancer stem cell activity through inhibiting GPR137 expression., PMID:38021163

Screening and Identifying Reference Genes for Erythrocyte Production from Cord Blood CD34+ Cells Exposed to Hypoxia., PMID:38011643

DYNC1H1 variants associated with infant-onset epilepsy without neurodevelopmental disorders., PMID:37903666

Aberrant dynein function promotes TDP-43 aggregation and upregulation of p62 in male mice harboring transgenic human TDP-43., PMID:37498094

Expanding the phenotype of DYNC1H1-associated diseases with a rare variant resulting in spinal muscular atrophy with lower extremity predominance (SMA-LED) and upper motor neuron signs., PMID:37395972

Case report: Genotype and phenotype of DYNC1H1-related malformations of cortical development: a case report and literature review., PMID:37181555

Interactome-Based Machine Learning Predicts Potential Therapeutics for COVID-19., PMID:37163139

Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients., PMID:37139238

[Clinical and genetic characteristics of 9 rare cases with coexistence of dual genetic diagnoses]., PMID:37011981

A human dynein heavy chain mutation impacts cortical progenitor cells causing developmental defects, reduced brain size and altered brain architecture., PMID:36933672

Muscle and bone characteristics of a Chinese family with spinal muscular atrophy, lower extremity predominant 1 (SMALED1) caused by a novel missense DYNC1H1 mutation., PMID:36882741

[Analysis of 4 children with DYNC1H1 gene related spinal muscular atrophy with lower extremity predominant 1]., PMID:36720598

Arf-like Protein 2 (ARL2) Controls Microtubule Neogenesis during Early Postnatal Photoreceptor Development., PMID:36611941

Non-synonymous, synonymous, and non-coding nucleotide variants contribute to recurrently altered biological processes during retinoblastoma progression., PMID:36550020

Ocular manifestations in a 2 year-old patient with a DYNC1H1 mutation., PMID:36537327

Generation of FOUR iPSC lines (CRICKi004-A; CRICKi005-A; CRICKi006-A, CRICKi007-A) from Spinal muscle atrophy patients with lower extremity dominant (SMALED) phenotype., PMID:36332468

A conditional null allele of Dync1h1 enables targeted analyses of dynein roles in neuronal length sensing., PMID:36218033

DYNC1H1-related epilepsy: Genotype-phenotype correlation., PMID:36175372

Phenotypic and Genetic Heterogeneity of Adult Patients with Hereditary Spastic Paraplegia from Serbia., PMID:36139378

Identification of a 6-RBP gene signature for a comprehensive analysis of glioma and ischemic stroke: Cognitive impairment and aging-related hypoxic stress., PMID:36118697

NudCD1 as a prognostic marker in colorectal cancer and its role in the upregulation of cellular spindle assembly checkpoint genes and LIS1 pathways., PMID:36104662

Expanding the Phenotypic and Genetic Spectrum of Neuromuscular Diseases Caused by DYNC1H1 Mutations., PMID:35899263

DYNC1H1 de novo mutation, spinal muscular atrophy and attention problems., PMID:35606327

A Prognosis Marker Dynein Cytoplasmic 1 Heavy Chain 1 Correlates with EMT and Immune Signature in Liver Hepatocellular Carcinoma by Bioinformatics and Experimental Analysis., PMID:35601740

The crosstalk signals of Sodium Tanshinone ⅡA Sulfonate in rats with cerebral ischemic stroke: Insights from proteomics., PMID:35561426

Rapid assessment of the temporal function and phenotypic reversibility of neurodevelopmental disorder risk genes in Caenorhabditis elegans., PMID:35363276

De novo DYNC1H1 mutation causes infantile developmental and epileptic encephalopathy with brain malformations., PMID:35099838

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human DYNC1H1 Protein, N-His [YHG75501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only